Our work aligns with the emerging literature that reveals EphA2’s role in immune-mediated mechanisms, in addition to its well-studied tumor-intrinsic mechanisms, that promote cancer progression in multiple tumor types. The gene discussed is EPHA2; the disease is neoplasm.